GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO

Watchlist Manager
GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd
NSE:GLAXO
Watchlist
Price: 2 457.15 INR 0.18% Market Closed
Market Cap: 416.3B INR
Have any thoughts about
GlaxoSmithKline Pharmaceuticals Ltd?
Write Note

Intrinsic Value

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 129.69 INR. Compared to the current market price of 2 457.15 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 54%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

GLAXO Intrinsic Value
1 129.69 INR
Overvaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
GlaxoSmithKline Pharmaceuticals Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for GLAXO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about GLAXO?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about GlaxoSmithKline Pharmaceuticals Ltd

Provide an overview of the primary business activities
of GlaxoSmithKline Pharmaceuticals Ltd.

What unique competitive advantages
does GlaxoSmithKline Pharmaceuticals Ltd hold over its rivals?

What risks and challenges
does GlaxoSmithKline Pharmaceuticals Ltd face in the near future?

Has there been any significant insider trading activity
in GlaxoSmithKline Pharmaceuticals Ltd recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/S
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/E
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/OCF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/FCFE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide P/B
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/S
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/GP
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/EBITDA
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/EBIT
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/OCF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/FCFF
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide EV/IC
for GlaxoSmithKline Pharmaceuticals Ltd.

Show me price targets
for GlaxoSmithKline Pharmaceuticals Ltd made by professional analysts.

What are the Revenue projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past Revenue estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the Net Income projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past Net Income estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the EPS projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past EPS estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

What are the EBIT projections
for GlaxoSmithKline Pharmaceuticals Ltd?

How accurate were the past EBIT estimates
for GlaxoSmithKline Pharmaceuticals Ltd?

Compare the revenue forecasts
for GlaxoSmithKline Pharmaceuticals Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of GlaxoSmithKline Pharmaceuticals Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of GlaxoSmithKline Pharmaceuticals Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of GlaxoSmithKline Pharmaceuticals Ltd compared to its peers.

Compare the P/E ratios
of GlaxoSmithKline Pharmaceuticals Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing GlaxoSmithKline Pharmaceuticals Ltd with its peers.

Analyze the financial leverage
of GlaxoSmithKline Pharmaceuticals Ltd compared to its main competitors.

Show all profitability ratios
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROA
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROIC
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide ROCE
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Gross Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Operating Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Net Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide FCF Margin
for GlaxoSmithKline Pharmaceuticals Ltd.

Show all solvency ratios
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide D/E Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide D/A Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Interest Coverage Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Altman Z-Score Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Quick Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Current Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

Provide Cash Ratio
for GlaxoSmithKline Pharmaceuticals Ltd.

What is the historical Revenue growth
over the last 5 years for GlaxoSmithKline Pharmaceuticals Ltd?

What is the historical Net Income growth
over the last 5 years for GlaxoSmithKline Pharmaceuticals Ltd?

What is the current Free Cash Flow
of GlaxoSmithKline Pharmaceuticals Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for GlaxoSmithKline Pharmaceuticals Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
GlaxoSmithKline Pharmaceuticals Ltd

Current Assets 28B
Cash & Short-Term Investments 20.1B
Receivables 2.2B
Other Current Assets 5.7B
Non-Current Assets 7.6B
Long-Term Investments 111.4m
PP&E 3.1B
Intangibles 235.5m
Other Non-Current Assets 4.1B
Current Liabilities 15.2B
Accounts Payable 6.3B
Other Current Liabilities 9B
Non-Current Liabilities 2.5B
Long-Term Debt 64.7m
Other Non-Current Liabilities 2.5B
Efficiency

Earnings Waterfall
GlaxoSmithKline Pharmaceuticals Ltd

Revenue
35.1B INR
Cost of Revenue
-13.3B INR
Gross Profit
21.7B INR
Operating Expenses
-12.5B INR
Operating Income
9.3B INR
Other Expenses
-2.9B INR
Net Income
6.4B INR

Free Cash Flow Analysis
GlaxoSmithKline Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

GLAXO Profitability Score
Profitability Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
79/100
Profitability
Score

GlaxoSmithKline Pharmaceuticals Ltd's profitability score is 79/100. The higher the profitability score, the more profitable the company is.

GLAXO Solvency Score
Solvency Due Diligence

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Negative Net Debt
Low D/E
90/100
Solvency
Score

GlaxoSmithKline Pharmaceuticals Ltd's solvency score is 90/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GLAXO Price Targets Summary
GlaxoSmithKline Pharmaceuticals Ltd

Wall Street analysts forecast GLAXO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GLAXO is 2 966.93 INR with a low forecast of 2 646.2 INR and a high forecast of 3 412.5 INR.

Lowest
Price Target
2 646.2 INR
8% Upside
Average
Price Target
2 966.93 INR
21% Upside
Highest
Price Target
3 412.5 INR
39% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for GLAXO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for GLAXO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

GLAXO Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

GlaxoSmithKline Pharmaceuticals Ltd Logo
GlaxoSmithKline Pharmaceuticals Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

418.6B INR

Dividend Yield

1.79%

Description

GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. The company is headquartered in Mumbai, Maharashtra and currently employs 3,840 full-time employees. The firm is engaged in the business of manufacturing, distributing, and trading in pharmaceuticals. The company manufactures medicinal substances used in the manufacture of pharmaceuticals, such as antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts, and esters; glycosides and vegetable alkaloids, and chemically pure sugar. The company offers a range of prescription medicines, vaccines, and consumer healthcare products. Its medicine portfolio includes Adartrel, Bactroban, Combodart, and Duodart. Its vaccines portfolio includes Ambirix, Cervarix, Fendrix, and Havrix. The Company’s products include Betamethasone, Potassium Clavulanate with Amoxycillin and Pneumococcal Polysaccharide and Conjugate Vaccine. Its oral health products include Sensodyne, parodontax and Polident. Its manufacturing unit is located at Nashik.

Contact

MAHARASHTRA
Mumbai
Dr Annie Besant Road, Worli
+912224959595
india-pharma.gsk.com

IPO

1994-11-03

Employees

3 840

Officers

MD & Executive Director
Mr. Bhushan Akshikar
Whole-Time Director & CFO
Mr. Juby Chandy
Executive Vice President of Human Resources
Mr. Chinmay Sharma
Vice President of Technology
Ms. Aparajita Rajput
VP of Administration & Real Estate and Company Secretary
Mr. Ajay Avinash Nadkarni
Executive Vice President of Legal
Mr. Amit G. Pandey
Show More
Vice President of Ethics & Compliance
Ms. Simrat Sohal
Executive Vice President of Communications & Government Affairs
Mr. Ransom D'Souza
Executive Vice-President of Regulatory Affairs
Ms. Sukanya Choudhary
Executive Vice-President of Adult Vaccines
Mr. Shourov Mukherjee
Show Less

See Also

Discover More
What is the Intrinsic Value of one GLAXO stock?

The intrinsic value of one GLAXO stock under the Base Case scenario is 1 129.69 INR.

Is GLAXO stock undervalued or overvalued?

Compared to the current market price of 2 457.15 INR, GlaxoSmithKline Pharmaceuticals Ltd is Overvalued by 54%.

Back to Top